Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Irinotecan Hydrochloride Injection

Approval Number

国药准字H20223909

Company仁合熙德隆药业有限公司

Registration Date

May 4, 2023

Drug Information

Generic Name

盐酸伊立替康注射液

Dosage Form

注射剂

Strength

5ml:0.1g（按C₃₃H₃₈N₄O₆·HCl·3H₂O计）

Drug Type

化学药品

Registration Date

May 4, 2023

Company Information

Applicant Company

Company Name仁合熙德隆药业有限公司

Company Address

河南省郑州市中牟县官渡生物医药产业园区结义路20号

Manufacturing Company

Company Name仁合熙德隆药业有限公司

Company Address

河南省郑州市中牟县官渡生物医药产业园区结义路20号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy